VivoSim Labs, Inc. (VIVS): Free Cash Flow
-$10.83M
Year ended 2026-03-31
-$10.12M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$10.83M | n/m | 2026-07-14, From 2025-04-01 |
| 2025-03-31 | -$9.47M | n/m | 2026-07-14, From 2024-04-01 |
| 2024-03-31 | -$14.70M | n/m | 2025-06-05, From 2023-04-01 |
| 2023-03-31 | -$12.80M | n/m | 2024-05-31, From 2022-04-01 |
| 2022-03-31 | -$8.86M | n/m | 2023-07-14, From 2021-04-01 |
| 2021-03-31 | -$13.73M | n/m | 2022-06-10, From 2020-04-01 |
| 2020-03-31 | -$14.88M | n/m | 2021-06-15, From 2019-04-01 |
| 2019-03-31 | -$20.45M | n/m | 2020-05-28, From 2018-04-01 |
| 2018-03-31 | -$29.08M | n/m | 2019-06-03, From 2017-04-01 |
| 2017-03-31 | -$30.54M | n/m | 2018-05-31, From 2016-04-01 |
| 2016-03-31 | -$31.48M | n/m | 2018-05-31, From 2015-04-01 |
| 2015-03-31 | -$21.12M | n/m | 2017-06-07, From 2014-04-01 |
| 2014-03-31 | -$15.84M | n/a | 2016-06-09, From 2013-04-01 |
| No annual figure between 2012-12-31 and 2014-03-31. | |||
| 2012-12-31 | -$10.05M | n/m | 2015-06-09, From 2012-01-01 |
| 2011-12-31 | -$1.96M | n/a | 2014-06-10, From 2011-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | -$10.83M | n/m |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | -$62.06M | n/m |
| AIM ImmunoTech Inc. (AIM) | 2024-12-31 | -$14.91M | n/a |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | -$23.62M | n/a |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | -$7.48M | n/m |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | -$37.97M | n/m |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | -$43.64M | n/m |
| Prokidney Corp. (PROK) | 2025-12-31 | -$135.31M | n/m |
| Pluri Inc. (PLUR) | 2026-06-30 | -$20.22M | n/m |
Compare VIVS, ATYR, AIM, INMB side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗